Insider Transactions in Q4 2020 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2020
|
Timothy M Mayleben President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,700
+8.02%
|
$21,400
$2.1 P/Share
|
|
Nov 03
2020
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
200,000
+4.82%
|
$5,000,000
$25.31 P/Share
|